The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
Published: March 16, 2021 at 05:11AM
from NYT Health https://ift.tt/3cAb56i
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
Published: March 16, 2021 at 05:11AM
from NYT Health https://ift.tt/3cAb56i